New agents on the horizon in hepatocellular carcinoma.

New agents on the horizon in hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38074429
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Molecular therapies in hepatocellular carcinoma: what can we target?Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH studyTelomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma.Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.Hepatocellular Carcinoma: Current Questions and Future Directions.Pediatric hepatocellular carcinoma: challenges and solutions.Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas.New trends in the multidisciplinary treatment of liver tumors.
P2860

New agents on the horizon in hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38074429
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New agents on the horizon in hepatocellular carcinoma.
@en
type
label
New agents on the horizon in hepatocellular carcinoma.
@en
prefLabel
New agents on the horizon in hepatocellular carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
New agents on the horizon in hepatocellular carcinoma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932